Glioblasztóma: vizsgálatok itt: Spanyolország
10 trials · From ClinicalTrials.gov, checked 2026. november 11.. Ask the study team whether a trial fits you.
- 1/2. fázisTaking peopleA Study of Zedoresertib (Debio 0123) in Combination With Temozolomide in Adult Participants With Recurrent or Progressive Glioblastoma and of Zedoresertib (Debio 0123) in Combination With Temozolomide and Radiotherapy in Adult Participants With Newly Diagnosed Glioblastoma
- Where
- Barcelona, Donostia, Madrid, Pamplona, Valencia
- Életkor
- 18 év and over
- People
- 116 worldwide
- Run by
- Debiopharm International SA
See details and how to joinNCT05765812 · EU 2022-502156-31-00 - 1/2. fázisTaking peopleA Study of PRMT5 Inhibitor BAY 3713372 in Participants With MTAP-deleted Solid Tumors
- Where
- Barcelona, Logroño, Madrid, Málaga, Pamplona, Pozuelo de Alarcón, Valencia
- Életkor
- 18 év and over
- People
- 450 worldwide
- Run by
- Bayer
See details and how to joinNCT06914128 · EU 2025-520623-24-00 - No phaseNot yet taking people in SpanyolországAn Optimization Study Evaluating Safety and Efficacy of the Y-90 Glioblastoma (GBM) Device in Patients With Recurrent GBM
- Where
- Barcelona
- Életkor
- 18 év and over
- People
- 30 worldwide
- Run by
- Boston Scientific Corporation
See details and how to joinNCT07867886 - 1/2. fázisTaking peopleA Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations
- Where
- Barcelona, Esplugues De Llobregat, Madrid, Pamplona, Sevilla, Valencia
- Életkor
- Up to 25 év
- People
- 75 worldwide
- Run by
- Turning Point Therapeutics, Inc.
See details and how to joinNCT04094610 · EU 2023-506464-14-00 - 3. fázisTaking peopleLomustine With and Without Reirradiation for First Progression of Glioblastoma: a Randomized Phase III Study
- Where
- Badalona, L'Hospitalet de Llobregat, Madrid
- Életkor
- 18 év and over
- People
- 411 worldwide
- Run by
- European Organisation for Research and Treatment of Cancer - EORTC
See details and how to joinNCT05904119 · EU 2023-505267-36-00 - 1/2. fázisTaking peopleStudy in Children and Adolescents of 177Lu-DOTATATE (Lutathera®) Combined With the PARP Inhibitor Olaparib for the Treatment of Recurrent or Relapsed Solid Tumours Expressing Somatostatin Receptor (SSTR) (LuPARPed).
- Where
- Boadilla del Monte
- Életkor
- 3 év and over
- People
- 25
- Run by
- Fundación de investigación HM
See details and how to joinNCT06607692 · EU 2024-512613-40-00 - 2. fázisTaking peopleSurgery for Recurrent Glioblastoma
- Where
- Barcelona
- Életkor
- 18 év and over
- People
- 120 worldwide
- Run by
- Insel Gruppe AG, University Hospital Bern
See details and how to joinNCT02394626 - No phaseTaking peopleFeasibility of ONCOhabitats for Surgical and Treatment Planning in IDH-Wildtype Glioblastoma (SINUE)
- Where
- Alicante, Barcelona, Murcia, Santa Cruz de Tenerife, Valencia
- Életkor
- 18 év and over
- People
- 140
- Run by
- Juan M Garcia-Gomez
See details and how to joinNCT07111195 - 2. fázisTaking peopleAPL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors
- Where
- Badalona, Barcelona, L'Hospitalet de Llobregat, Madrid, Valencia
- Életkor
- 18 év and over
- People
- 497 worldwide
- Run by
- Apollomics Inc.
See details and how to joinNCT03175224 · EU 2024-514542-37-00 - 1. fázisTaking peopleNeoadjuvant Radio-chemotherapy Safety Pilot Study in Patients With Glioblastoma
- Where
- Madrid
- Életkor
- 18 év to 75 év
- People
- 12
- Run by
- Hospital San Carlos, Madrid
See details and how to joinNCT06418113